Tennessee Oncology/SCRI — Nashville, Tennessee

Tennessee Oncology/SCRI is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Tennessee Oncology/SCRI has participated in 1 clinical trials.

Therapeutic areas: Locally Advanced or Metastatic Breast Cancer.

Sponsors: Sermonix Pharmaceuticals Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nashville

Browse all research sites in Tennessee · View every site in Nashville

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tennessee Oncology/SCRI?

Tennessee Oncology/SCRI has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tennessee Oncology/SCRI conducted?

Tennessee Oncology/SCRI has 1 clinical trials on record. Their work covers Locally Advanced or Metastatic Breast Cancer.

Is Tennessee Oncology/SCRI accredited by Crixeo Clinical Trials?

Tennessee Oncology/SCRI has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tennessee Oncology/SCRI?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.